Suzhou Hepathera Biotech Co., Ltd.

This study tests two experimental injections, HT-101 and HT-102, in 60 adults with chronic hepatitis B who are already on standard antiviral therapy. The goal is to see if the combination can lower hepatitis B surface antigen (HBsAg) to undetectable levels and keep the virus unde…

This study tests two experimental injections, HT-101 and HT-102, in 86 adults with chronic hepatitis B who are already on standard antiviral medication. The goal is to see if adding these injections is safe and how the body processes them. Participants receive the injections ever…